When

Thursday, September 19, 2019 from 11:30 AM to 12:00 PM PDT
Add to Calendar

Where

This is an online event.

Contact

UCLA Health Webinars
UCLA Health
contactuclahealth@mednet.ucla.edu

PARP Inhibitors for the Treatment of Ovarian Cancer: New Opportunities and Limitations

Join UCLA oncologist Gottfried E. Konecny, MD, for an update on the PARP inhibitors olaparib, niraparib, and rucaparib, which have been approved for the treatment of ovarian cancers. Dr. Konecny will also discuss how to proactively plan for and manage treatment-related toxicities.

* Required information

Personal Information

  • *
  • *
  • *
  • *

Receive emails about upcoming webinars by joining our mailing list

Register